Trademark: RELIEFACYN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for RELIEFACYN
We do not have any records of a proof of use for RELIEFACYN at this moment.
Possible trademark infringements of RELIEFACYN
Basic Information about RELIEFACYN
- Serial Number
- 97095311
- Filing Date
- 27 Oct 2021
- Registration Number
- 6993152
- Registration Date
- 28 Feb 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of RELIEFACYN on the blockchain with WikiTrademarks.io.
- First use of RELIEFACYN anywhere
- RELIEFACYN was first used on 27 Oct 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns RELIEFACYN?
1. Sonoma Pharmaceuticals, Inc. Boulder CO
2. Sonoma Pharmaceuticals, Inc. Boulder CO
3. Sonoma Pharmaceuticals, Inc. Woodstock GA
Correspondent
- Anne E. Naffziger
- LEYDIG, VOIT & MAYER, LTD.
- THE ATRIUM BUILDING, 1981 N. BROADWAY
- SUITE 375
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io